SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gg cox who wrote (13806)11/23/2004 4:06:01 AM
From: axial   of 14101
 
Arthritis Pills Little Use in Beating Pain -Study

Mon Nov 22, 7:02 PM ET

LONDON (Reuters) - Painkillers taken by millions of arthritis sufferers worldwide are actually of limited use in relieving symptoms, Norwegian scientists said on Tuesday.

Researchers from the University of Bergen said their findings suggested the drugs should be used only on a short-term basis and be prescribed much more critically in future.

Current guidelines in many countries recommend using non-steroidal anti-inflammatory drugs (NSAIDs), including so-called COX-2 inhibitors, for treating patients with osteoarthritis.

But there are mounting concerns about their safety, following the withdrawal of Merck & Co Inc's COX-2 drug Vioxx in September due to heart attack risk. At the same time, many older NSAIDs, such as naproxen and ibuprofen, can cause gastrointestinal problems.

Jan Magnus Bjordal and colleagues pooled the results of 23 previous clinical trials to find out just how useful all types of NSAIDs and COX-2 drugs were in relieving pain in patients with knee osteoarthritis, the most common form of the disease.

Their findings, published online by the British Medical Journal, showed that the drugs reduced pain in the short term only slightly better than placebo.

"We were surprised that the effects were so small. These drugs are very commonly used but their effect is below what many patients report as clinically relevant for them," Bjordal told Reuters.

Given the serious adverse effects that the drugs can cause, doctors needed to review carefully whether their use was justified, he said.

story.news.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext